ongoing treatment methods for HF primarily focus on neurohormonal blockades, including angiotensin-converting enzyme inhibitors (ACEIs), beta-blockers, and mineralocorticoid receptor antagonists. This evidence concerns the gene NR3C2 and hydrops fetalis.